Fecal markers of disease recurrence in IBD

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The ability to assess disease recurrence in patients with IBD is a complicated task. Endoscopy with mucosal biopsy remains the gold standard for assessing disease activity, while radiology examinations and laboratory tests play supportive roles. Cumulative radiation exposure, the risks of repeated, invasive endoscopic examinations, and poor testing characteristics of nonspecific, serological markers demonstrate how difficult it is to perform a simple assessment of disease activity. In recent years, fecal biomarkers have emerged as potential markers of disease activity. Through direct contact with the intestinal mucosa, these markers may be more specific markers of intestinal inflammation. In this review, we discuss fecal biomarkers and their role assessing recurrence of disease after medically and surgically induced remission.

Original languageEnglish (US)
Pages (from-to)15-21
Number of pages7
JournalInflammatory Bowel Disease Monitor
Volume11
Issue number1
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

Recurrence
Biomarkers
Intestinal Mucosa
Radiology
Endoscopy
Inflammation
Biopsy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Fecal markers of disease recurrence in IBD. / Khan, Omar; Raffals, Laura E. H.

In: Inflammatory Bowel Disease Monitor, Vol. 11, No. 1, 01.12.2010, p. 15-21.

Research output: Contribution to journalReview article

@article{779646a283aa4c64b04102f16da6fd5c,
title = "Fecal markers of disease recurrence in IBD",
abstract = "The ability to assess disease recurrence in patients with IBD is a complicated task. Endoscopy with mucosal biopsy remains the gold standard for assessing disease activity, while radiology examinations and laboratory tests play supportive roles. Cumulative radiation exposure, the risks of repeated, invasive endoscopic examinations, and poor testing characteristics of nonspecific, serological markers demonstrate how difficult it is to perform a simple assessment of disease activity. In recent years, fecal biomarkers have emerged as potential markers of disease activity. Through direct contact with the intestinal mucosa, these markers may be more specific markers of intestinal inflammation. In this review, we discuss fecal biomarkers and their role assessing recurrence of disease after medically and surgically induced remission.",
author = "Omar Khan and Raffals, {Laura E. H.}",
year = "2010",
month = "12",
day = "1",
language = "English (US)",
volume = "11",
pages = "15--21",
journal = "Inflammatory Bowel Disease Monitor",
issn = "1466-7401",
publisher = "Remedica Medical Education and Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Fecal markers of disease recurrence in IBD

AU - Khan, Omar

AU - Raffals, Laura E. H.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The ability to assess disease recurrence in patients with IBD is a complicated task. Endoscopy with mucosal biopsy remains the gold standard for assessing disease activity, while radiology examinations and laboratory tests play supportive roles. Cumulative radiation exposure, the risks of repeated, invasive endoscopic examinations, and poor testing characteristics of nonspecific, serological markers demonstrate how difficult it is to perform a simple assessment of disease activity. In recent years, fecal biomarkers have emerged as potential markers of disease activity. Through direct contact with the intestinal mucosa, these markers may be more specific markers of intestinal inflammation. In this review, we discuss fecal biomarkers and their role assessing recurrence of disease after medically and surgically induced remission.

AB - The ability to assess disease recurrence in patients with IBD is a complicated task. Endoscopy with mucosal biopsy remains the gold standard for assessing disease activity, while radiology examinations and laboratory tests play supportive roles. Cumulative radiation exposure, the risks of repeated, invasive endoscopic examinations, and poor testing characteristics of nonspecific, serological markers demonstrate how difficult it is to perform a simple assessment of disease activity. In recent years, fecal biomarkers have emerged as potential markers of disease activity. Through direct contact with the intestinal mucosa, these markers may be more specific markers of intestinal inflammation. In this review, we discuss fecal biomarkers and their role assessing recurrence of disease after medically and surgically induced remission.

UR - http://www.scopus.com/inward/record.url?scp=84863846166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863846166&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84863846166

VL - 11

SP - 15

EP - 21

JO - Inflammatory Bowel Disease Monitor

JF - Inflammatory Bowel Disease Monitor

SN - 1466-7401

IS - 1

ER -